striae distensae. Atrophic disorder of skin, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients are injected with SVF cells isolated from adipose tissue with erbium YAG laser for 2 sessions with an interval of 1 month. Intervention 2: Control group: P
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Diagnosis of striae distensae based on the diagnosis of a dermatologist Patient satisfaction with the study Age less than 50 years and more than 18 years
Exclusion criteria
Exclusion criteria: Use any treatment to eliminate striae in the last three months Existence of skin lesions and diseases such as skin cancer wart Skin infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Striae size. Timepoint: Before and 3 months after the intervention. Method of measurement: biometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Satisfaction. Timepoint: Three months after treatment. Method of measurement: Questionnaire.;Pain. Timepoint: Injection time. Method of measurement: questionnaire.;Inflammation. Timepoint: 1-5 hours after injection. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed